Free Trial

Curaleaf (OTCMKTS:CURLF) Sees Large Volume Increase - What's Next?

Curaleaf logo with Medical background

Key Points

  • Curaleaf Holdings, Inc. experienced a significant increase in trading volume, with 1,541,046 shares traded, up 112% from the previous session's volume.
  • Cormark upgraded Curaleaf from a "hold" to a "moderate buy" rating, signaling increased analyst confidence in the stock.
  • The company reported a quarterly earnings per share of ($0.06), surpassing analysts' expectations by $0.01, despite having a negative net margin of 18.08%.
  • Five stocks to consider instead of Curaleaf.

Shares of Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) saw strong trading volume on Tuesday . 1,541,046 shares were traded during mid-day trading, an increase of 112% from the previous session's volume of 726,477 shares.The stock last traded at $2.84 and had previously closed at $2.76.

Analyst Upgrades and Downgrades

Separately, Cormark upgraded shares of Curaleaf from a "hold" rating to a "moderate buy" rating in a report on Friday, August 8th.

Read Our Latest Analysis on Curaleaf

Curaleaf Stock Down 9.5%

The stock has a market capitalization of $1.78 billion, a P/E ratio of -8.31 and a beta of 0.69. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.47 and a quick ratio of 0.70. The stock's fifty day moving average is $1.27 and its two-hundred day moving average is $1.11.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported ($0.06) EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 14.61%. As a group, research analysts predict that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current fiscal year.

About Curaleaf

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Recommended Stories

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

September Rate Cuts: 3 Stocks Set to Benefit Most
Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines